IXJ – iShares Global Healthcare ETF
iShares Global Healthcare ETF (IXJ) is a Health ETF, issued by iShares, $4.6B in assets, 0.42% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.3%, 1 year +20.4%.
Tracks global healthcare sector index. Invests in component securities and economically similar investments, with limited exposure to futures, options, and swaps.
Top holdings
- LLY – Eli Lilly and Company, 11.1%
- JNJ – Johnson & Johnson, 6.3%
- ABBV – AbbVie Inc, 5.2%
- UNH – UnitedHealth Group Incorporated, 4.4%
- ROP – Roche Holding AG, 3.7%
- NOVN – Novartis AG, 3.4%
- AZN – AstraZeneca PLC, 3.1%
- TMO – Thermo Fisher Scientific Inc, 2.9%
- AMGN – Amgen Inc, 2.9%
- GILD – Gilead Sciences Inc, 2.3%
- PFE – Pfizer Inc, 2.1%
- ABT – Abbott Laboratories, 2.0%
- ISRG – Intuitive Surgical Inc, 1.8%
- DHR – Danaher Corporation, 1.7%
- VRTX – Vertex Pharmaceuticals Inc, 1.5%
- NOVO-B – Novo Nordisk A/S, 1.5%
- BMY – Bristol-Myers Squibb Company, 1.4%
- MDT – Medtronic PLC, 1.4%
- MCK – McKesson Corporation, 1.4%
- CVS – CVS Health Corp, 1.4%
- SYK – Stryker Corporation, 1.2%
- GSK – GSK plc, 1.1%
- ELV – Elevance Health Inc, 1.1%
- SAN – Sanofi SA, 1.1%
- MRNA – Moderna Inc, 1.0%